
EP 157: From HFpEF to AF: Dissecting the ACC 2026 Trials That Matter
Apr 20, 2026 - 00:46:37
Radio and PodcastLive Radio & Podcasts
In this essential episode of Parallax, Dr Ankur Kalra is joined by Dr Carolyn Ho, Professor of Medicine at Harvard Medical School and Medical Director of the Cardiovascular Genetics Program at Brigham and Women's Hospita...
EP 139: The Genetic Revolution in HCM: Mapping Family Risk to Targeted Treatment is an episode from Parallax by Ankur Kalra by Parallax by Ankur Kalra. In this essential episode of Parallax, Dr Ankur Kalra is joined by Dr Carolyn Ho, Profes...
This episode belongs to Parallax by Ankur Kalra.
Use the player on this page to stream the episode online.
Published Jul 28, 2025, 00:28:29 long, audio available.
In this essential episode of Parallax, Dr Ankur Kalra is joined by Dr Carolyn Ho, Professor of Medicine at Harvard Medical School and Medical Director of the Cardiovascular Genetics Program at Brigham and Women's Hospital, for a comprehensive discussion on how genetic testing is reshaping hypertrophic cardiomyopathy management. The conversation explores the VANISH HCM trial results, which showed that valsartan can slow disease progression in young, asymptomatic individuals with early sarcomeric HCM. Dr Ho discusses how this evidence influenced the 2024 HCM guidelines and created new opportunities for disease-modifying therapy before clinical symptoms appear. The episode also examines emerging gene-based therapeutics, from current adeno-associated virus approaches to future CRISPR technologies that could address the underlying genetic causes of HCM. Dr Ho addresses practical considerations for clinicians, including when to initiate genetic testing, how to manage family screening, and the promise of AI-assisted screening tools. The discussion highlights both current therapeutic options and the evolving landscape of precision medicine in inherited cardiovascular disease. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.
You can listen to EP 139: The Genetic Revolution in HCM: Mapping Family Risk to Targeted Treatment online on Radio and Podcast. Open the player on this page to stream the available audio.
EP 139: The Genetic Revolution in HCM: Mapping Family Risk to Targeted Treatment is an episode from Parallax by Ankur Kalra by Parallax by Ankur Kalra.
This episode is 00:28:29 long.
This episode was published on Jul 28, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from Parallax by Ankur Kalra when more episodes are available from the podcast feed.
You can listen to EP 139: The Genetic Revolution in HCM: Mapping Family Risk to Targeted Treatment on this page when the episode audio is available from the podcast feed.
EP 139: The Genetic Revolution in HCM: Mapping Family Risk to Targeted Treatment is from Parallax by Ankur Kalra by Parallax by Ankur Kalra.
Published Jul 28, 2025 and 00:28:29 long